News
WASHINGTON (AP) — Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy.
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
The recalled iStore-branded magnetic portable chargers could overheat and expand during normal use, posing a fire hazard, ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results